Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2925
0.245 %
$ 75.4 M
Market Cap
-0.95
P/E
ADAP - CASH & EQUIVALENTS
Cash & Equivalents ADAP - Adaptimmune Therapeutics plc
91.1 M
LAST VALUE
-8.15%
2 YEAR CAGR
12.57%
5 YEAR CAGR
5.92%
10 YEAR CAGR